Skip to main content
Log in

Evaluation of the Cardiovascular Risk in Patients with Subclinical Cushing Syndrome Before and After Surgery

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

The widespread use of ultrasound, computerized tomography, and magnetic resonance imaging has led to an increase in the number of incidental adrenal masses identified. Asymptomatic incidentally discovered adrenal masses may indicate that subclinical Cushing syndrome (SCS) is not uncommon. We aimed to evaluate the cardiovascular risk of patients with SCS before and after surgery.

Methods

An autonomous cortisol-producing tumor was detected in 11 of 94 patients with adrenal incidentaloma between 1995 and 2005. Twenty-eight patients suffering from classical Cushing syndrome (CS) associated with unilateral adrenocortical adenoma, who were treated at our department in the same period, served as a control group. Cardiovascular risk factors such as blood pressure, body mass index, and lipid profile were evaluated before and 1 year after surgery.

Results

The frequency of hypertension (61% versus 63%), obesity (46% versus 55%), diabetes mellitus (50% versus 36%), hypercholesterolemia (39% versus 36%), and low HDL cholesterol (28% versus 36%) were not significantly different between CS and SCS patients, respectively. Adverse cardiovascular risk profile improved 1 year after adrenalectomy in both groups, although the changes were not significant with respect to body mass index, frequency of diabetes, and hyperlipidemia in SCS patients. But frequency of systolic/diastolic hypertension decreased significantly in this group.

Conclusions

These findings indicate that the increased incidence of cardiovascular risk factors commonly observed in classical CS, is also present in SCS. Unilateral adrenalectomy does not always lead to significant improvements in cardiovascular risk profile in SCS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ross NS. Epidemiology of Cushing’s syndrome and subclinical disease. Endocrinol Metab Clin North Am 1994;23:539–546

    PubMed  CAS  Google Scholar 

  2. Terzolo M, Osella G, Alì A, et al. Subclinical Cushing’s syndrome in adrenal incidentaloma. Clin Endocrinol (Oxf) 1998;48:89–97

    Article  CAS  Google Scholar 

  3. Siren J, Tervahartiala P, Sivula A, et al. Natural course of adrenal incidentalomas: seven-year follow-up-up study. World J Surg 2000;245:579–582

    Google Scholar 

  4. Terzolo M, Pia A, Alì A, et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 2002;87:998–1003

    Article  PubMed  CAS  Google Scholar 

  5. Nawar R, Aron D. Adrenal incidentalomas—a continuing management dilemma. Endocr Relat Cancer 2005;12:585–598

    Article  PubMed  CAS  Google Scholar 

  6. Mansmann G, Lau J, Balk E, et al. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 2004;25:309–340

    Article  PubMed  Google Scholar 

  7. Braunstein GD. Management of the clinically inapparent adrenal mass. Ann Intern Med 2004;140:401–402

    Google Scholar 

  8. Copeland PM. Management of the clinically inapparent adrenal mass. Ann Intern Med 2004;140:401

    PubMed  Google Scholar 

  9. Sippel RS, Chen H. Subclinical Cushing’s syndrome in adrenal incidentalomas. Surg Clin North Am 2004;84:875–885

    Article  PubMed  Google Scholar 

  10. Reincke M. Subclinical Cushing’s syndrome. Endocrinol Metab Clin North Am 2000;29:43–56

    Article  PubMed  CAS  Google Scholar 

  11. Bloom LS, Libertino JA. Surgical management of Cushing’s syndrome. Urol Clin North Am 1989;16:547–565

    PubMed  CAS  Google Scholar 

  12. Barzon L, Fallo F, Sonino N, et al. Development of overt Cushing’s syndrome in patients with adrenal incidentaloma. Eur J Endocrinol 2002;146:61–66

    Article  PubMed  CAS  Google Scholar 

  13. Charbonnel B, Chatal JF, Ozanne P. Does the corticoadrenal adenoma with “pre-Cushing’s syndrome” exist? J Nucl Med 1981;22:1059–1061

    PubMed  CAS  Google Scholar 

  14. Rossi R, Tauchmanova L, Luciano A, et al. Subclinical Cushing’s syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 2000;85:1440–1448

    Article  PubMed  CAS  Google Scholar 

  15. Royal College of Physicians. Obesity. A report of the Royal College of Physicians. J R Coll Physicians Lond 1983;17:5–65

    Google Scholar 

  16. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults JAMA. 2001;285:2486–2497

  17. Kaye TB, Crapo L. The Cushing’s syndrome: an update on diagnostic tests. Ann Intern Med 1990;112:434–444

    PubMed  CAS  Google Scholar 

  18. Angeli A, Terzolo M. Adrenal incidentaloma—a modern disease with old complications. J Clin Endocrinol Metab 2002;87:4869–4871

    Article  PubMed  CAS  Google Scholar 

  19. Bernini G, Moretti A, Iacconi P, et al. Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. Eur J Endocrinol 2003;148:213–219

    Article  PubMed  CAS  Google Scholar 

  20. Faggiano A, Pivonello R, Spiezia S, et al. Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing’s disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 2003;88:2527–2533

    Article  PubMed  CAS  Google Scholar 

  21. Emral R, Uysal AR, Asik M, et al. Prevalence of subclinical Cushing’s syndrome in 70 patients with adrenal incidentaloma: clinical, biochemical and surgical outcomes. Endocr J 2003;50:399–408

    Article  PubMed  Google Scholar 

  22. Torlontano M, Chiodini I, Pileri M, et al. Altered bone mass and turnover in female patients with adrenal incidentaloma: the effect of subclinical hypercortisolism. J Clin Endocrinol Metab 1999;84:2381–2385

    Article  PubMed  CAS  Google Scholar 

  23. Tauchmanova L, Rossi R, Biondi B, et al. Patients with subclinical Cushing’s syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 2002;87:4872–4878

    Article  PubMed  CAS  Google Scholar 

  24. Reincke M, Nieke J, Krestin GP, et al. Preclinical Cushing’s syndrome in adrenal “incidentalomas”: comparison with adrenal Cushing’s syndrome. J Clin Endocrinol Metab 1992;75:826–832

    Article  PubMed  CAS  Google Scholar 

  25. Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab 2000;85:637–644

    Article  PubMed  CAS  Google Scholar 

  26. Mirallie E, Jafari M, Pattou F, et al. Outcome of non-operated adrenal masses in 126 patients observed from 1986 to 1999. Ann Chir 2001;126:212–220

    Article  PubMed  CAS  Google Scholar 

  27. Terzolo M, Reimondo G, Bovio S, et al. Subclinical Cushing’s syndrome. Pituitary 2004;7:217–223

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yeşim Erbil MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Erbil, Y., Ademoğlu, E., Özbey, N. et al. Evaluation of the Cardiovascular Risk in Patients with Subclinical Cushing Syndrome Before and After Surgery. World J. Surg. 30, 1665–1671 (2006). https://doi.org/10.1007/s00268-005-0681-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-005-0681-x

Keywords

Navigation